Hepatic decompensation/serious adverse events in post-liver

发布时间：2022-08-07 22:37

　　AIM: To determine the safety profile of new hepatitis C virus（HCV） treatments in liver transplant（LT） recipients with recurrent HCV infection.METHODS: Forty-two patients were identified with recurrent HCV infection that underwent LT at least 12 mo prior to initiating treatment with a Sofosbuvir-based regimen during December 2013-June 2014. Cases were patients who experienced hepatic decompensation and/or serious adverse events（SAE） during or within one month of completing treatment. Controls had... 

【文章页数】：11 页

【参考文献】：
期刊论文
[1]Management of hepatitis C infection before and after liver transplantation[J]. Stefano Fagiuoli,Roberto Ravasio,Maria Grazia Lucà,Anna Baldan,Silvia Pecere,Alessandro Vitale,Luisa Pasulo.  World Journal of Gastroenterology. 2015(15)



本文编号：3671167